Literature DB >> 19442525

A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone.

David J Lapinsky1, Shaili Aggarwal, Yurong Huang, Christopher K Surratt, John R Lever, James D Foster, Roxanne A Vaughan.   

Abstract

Non-tropane-based photoaffinity ligands for the dopamine transporter (DAT) are relatively unexplored in contrast to tropane-based compounds such as cocaine. In order to fill this knowledge gap, a ligand was synthesized in which the aromatic ring of pyrovalerone was substituted with a photoreactive azido group. The analog 1-(4-azido-3-iodophenyl)-2-pyrrolidin-1-yl-pentan-1-one demonstrated appreciable binding affinity for the DAT (K(i)=78+/-18 nM), suggesting the potential utility of a radioiodinated version in structure-function studies of this protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442525      PMCID: PMC2696686          DOI: 10.1016/j.bmc.2009.04.057

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  29 in total

1.  Photoaffinity labeling of the mammalian dopamine transporter.

Authors:  F R Sallee; E L Fogel; E Schwartz; S M Choi; D P Curran; H B Niznik
Journal:  FEBS Lett       Date:  1989-10-09       Impact factor: 4.124

2.  Probes for the cocaine receptor. Potentially irreversible ligands for the dopamine transporter.

Authors:  F I Carroll; Y Gao; P Abraham; A H Lewin; R Lew; A Patel; J W Boja; M J Kuhar
Journal:  J Med Chem       Date:  1992-05-15       Impact factor: 7.446

3.  Design and synthesis of a novel photoaffinity ligand for the dopamine and serotonin transporters based on 2beta-carbomethoxy-3beta-biphenyltropane.

Authors:  Amy Hauck Newman; Joo Hwan Cha; Jianjing Cao; Theresa Kopajtic; Jonathan L Katz; M Laura Parnas; Roxanne Vaughan; John R Lever
Journal:  J Med Chem       Date:  2006-11-02       Impact factor: 7.446

4.  Novel tropane-based irreversible ligands for the dopamine transporter.

Authors:  M F Zou; T Kopajtic; J L Katz; S Wirtz; J B Justice; A H Newman
Journal:  J Med Chem       Date:  2001-12-06       Impact factor: 7.446

5.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

6.  Design, synthesis, and characterization of a novel, 4-[2-(diphenylmethoxy)ethyl]-1-benzyl piperidine-based, dopamine transporter photoaffinity label.

Authors:  A K Dutta; X S Fei; R A Vaughan; J D Gaffaney; N Wang; J R Lever; M E Reith
Journal:  Life Sci       Date:  2001-03-09       Impact factor: 5.037

7.  Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.

Authors:  S P Berger; R E Martenson; P Laing; A Thurkauf; B Decosta; K C Rice; S M Paul
Journal:  Mol Pharmacol       Date:  1991-04       Impact factor: 4.436

Review 8.  Neurobiology of cocaine abuse.

Authors:  W L Woolverton; K M Johnson
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

9.  Dopamine transport sites selectively labeled by a novel photoaffinity probe: 125I-DEEP.

Authors:  D E Grigoriadis; A A Wilson; R Lew; J S Sharkey; M J Kuhar
Journal:  J Neurosci       Date:  1989-08       Impact factor: 6.167

10.  Structure-activity relationship comparison of (S)-2beta-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes and (R)-2beta-substituted 3beta-(3,4-dichlorophenyl)tropanes at the dopamine transporter.

Authors:  Mu-Fa Zou; Theresa Kopajtic; Jonathan L Katz; Amy Hauck Newman
Journal:  J Med Chem       Date:  2003-07-03       Impact factor: 7.446

View more
  5 in total

1.  Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling.

Authors:  David J Lapinsky; Ranganadh Velagaleti; Nageswari Yarravarapu; Yi Liu; Yurong Huang; Christopher K Surratt; John R Lever; James D Foster; Rejwi Acharya; Roxanne A Vaughan; Howard M Deutsch
Journal:  Bioorg Med Chem       Date:  2010-11-04       Impact factor: 3.641

2.  (±)-2-(N-tert-Butylamino)-3'-[(125)I]-iodo-4'-azidopropiophenone: a dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin, Zyban).

Authors:  David J Lapinsky; Shaili Aggarwal; Tammy L Nolan; Christopher K Surratt; John R Lever; Rejwi Acharya; Roxanne A Vaughan; Akash Pandhare; Michael P Blanton
Journal:  Bioorg Med Chem Lett       Date:  2011-11-04       Impact factor: 2.823

3.  Evolution of a Compact Photoprobe for the Dopamine Transporter Based on (±)-threo-Methylphenidate.

Authors:  David J Lapinsky; Nageswari Yarravarapu; Tammy L Nolan; Christopher K Surratt; John R Lever; Michael Tomlinson; Roxanne A Vaughan; Howard M Deutsch
Journal:  ACS Med Chem Lett       Date:  2012-03-11       Impact factor: 4.345

4.  Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram.

Authors:  Vivek Kumar; Nageswari Yarravarapu; David J Lapinsky; Danielle Perley; Bruce Felts; Michael J Tomlinson; Roxanne A Vaughan; L Keith Henry; John R Lever; Amy Hauck Newman
Journal:  J Med Chem       Date:  2015-07-08       Impact factor: 7.446

5.  From linked open data to molecular interaction: studying selectivity trends for ligands of the human serotonin and dopamine transporter.

Authors:  Barbara Zdrazil; Eva Hellsberg; Michael Viereck; Gerhard F Ecker
Journal:  Medchemcomm       Date:  2016-07-22       Impact factor: 5.121

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.